JCU - Abstracts of the BAUS 2018 Scientific Meeting - June 2018 - 74

Journal of Clinical Urology 11(1S)

non-high risk patients but notices there is insufficient high
quality comparative evidence to support the routine
adoption of XPS laser P.V.P. in high-risk patients.
NICE identifies high-risk patients as:
x High risk of bleeding
x Prostate > 100 mls
x Urinary retention
Methods: This retrospective study reviews a single surgeon's experience of treating high risk patients with XPS
PVP. All patients had laser PVP while taking anti-coagulants,
anti-platelet agents or both.
Patients:
x
x
x
x
x
x
x
x
x

n= 374 were treated
n = 91 had urinary retention (AUR)
n = 103 age > 80 years
n = 54 had prostates > 80mls
Mean age = 71 years (44-96 yrs)
Haematuria from BPH = 40
Troublesome L.U.T.S. = 243
54% were classed ASA III
5.4% were classed ASA IV

Results: There were no perioperative blood transfusions.
x n = 301 were managed with Bananno supra-pubic
catheter (SPC) (proxy for no haematuria)
x n = 40 Bananno SPC & temporary haematuria (UC
1-2 hours)
x n = 25 U.C. on irrigation overnight
x n = 270 Discharged Day 1 post-op
x n = 10 Re-admitted with clot retention
x n = 12 Re-admitted with recurrent retention
Conclusion: This retrospective study shows that in experienced hands XPS laser PVP is a safe and effective treatment in patients with one or more high-risk factors.
Despite all patients having significant co-morbidities the
incidence of cardiovascular and haematological complications were less than those reported for TURP in nonhigh-risk patients.

ePoster Session 9:
Renal Cancer and Testis Cancer
Wednesday 27 June
12:00 - 13:30
Room 4
Chairs: David Nicol & Archie Fernando
P9-1 Benign testicular tumour in nonpalpable scrotal lesions in patients with
abnormal testicular ultrasound

Phan Y1,2, Loh A2,3, Rosli M2, Anankumar A2,4, Lynn N2
County Hospital, United Kingdom, 2Royal Shrewsbury
Hospital, United Kingdom, 3Royal Stoke University Hospital, United
Kingdom, 4Worcestershire Royal Hospital, United Kingdom

1Hereford

Introduction: Radical orchidectomy may represent a life
changing experience for patients. Clinicians strive to accurately diagnose testicular malignancy through careful scrotal examination and testicular ultrasound prior to surgery.
Nevertheless, no investigation is 100% accurate. We aim
to find out the occurrence of benign testicular tumour in
men without palpable scrotal lesions but with abnormal
testicular ultrasound.
Methodology: All pathological outcomes of orchidectomies from Jan 2011 to Dec 2016 were retrospectively
analysed.
Results: 220 orchidectomies were performed during this
period. 146 patients with a mean age of 44 years old
underwent radical inguinal orchidectomies for possible
malignancies due to abnormal testicular ultrasound findings with or without palpable lesions. 115 of these patients
had palpable scrotal lesions. 101(88%) of these men had
malignant tumours on histopathology. 31 patients had no
palpable scrotal lesion but had abnormal testicular ultrasound findings that are suspicious of a testicular tumour.
Of these patients, 15 (48%) had malignant tumours while
16 patients (52%) had benign testicular tumours.
Conclusions: 88% patients with clinically palpable scrotal
tumour and ultrasound abnormality were found to have
malignant tumour. In contrast, only 52% patients were
found to have malignant tumours with ultrasound abnormality without a palpable lesion. Whilst this may not
change the need for surgical excision, it is an important
consideration in the pre-operative counseling of these
men and offer ultrasound surveillance in these men.
P9-2 Outcomes of testes-sparing surgery for
the treatment of testicular masses: a multicentre study
Ward K1, Almekaty K2, Kelly B1, Bhandari C2, Patel K1,
Patel P1, Garaffa G2, Shabbir M3, Minhas S2, Viney R1
1University Hospitals Birmingham NHS Foundation Trust, United
Kingdom, 2University College London Hospitals, United Kingdom,
3Guy's and St Thomas' NHS Foundation Trust, London, United
Kingdom

Introduction: Treatment of testicular masses by inguinal
orchidectomy (IO) can have psychological and functional
morbidity. This study evaluated the outcomes of testessparing surgery (TSS) in the treatment of testicular masses.
Methods: Between 2007 and 2017, 90 cases of TSS were
performed with Frozen section analysis (FSA) in 85 men.
Patients with testicular cancer, were followed-up with
post-operative ultrasound (US). Data were retrospectively
analysed from 3 tertiary centres.

Table of Contents for the Digital Edition of JCU - Abstracts of the BAUS 2018 Scientific Meeting - June 2018